Emergent Biosolutions, Inc. (EBS): Price and Financial Metrics

EBS POWR Grades

• Value is the dimension where EBS ranks best; there it ranks ahead of 85.39% of US stocks.
• The strongest trend for EBS is in Growth, which has been heading down over the past 178 days.
• EBS ranks lowest in Sentiment; there it ranks in the 1st percentile.

EBS Stock Summary

• As for revenue growth, note that EBS's revenue has grown -37.47% over the past 12 months; that beats the revenue growth of just 5.63% of US companies in our set.
• The volatility of EMERGENT BIOSOLUTIONS INC's share price is greater than that of 91.49% US stocks with at least 200 days of trading history.
• EMERGENT BIOSOLUTIONS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -119.64%, greater than the shareholder yield of only 5.26% of stocks in our set.
• Stocks that are quantitatively similar to EBS, based on their financial statements, market capitalization, and price volatility, are NOVT, CSGS, PRGS, MDRX, and CRNT.
• Visit EBS's SEC page to see the company's official filings. To visit the company's web site, go to www.emergentbiosolutions.com.

EBS Valuation Summary

• EBS's price/sales ratio is 0.4; this is 91.49% lower than that of the median Healthcare stock.
• EBS's price/earnings ratio has moved down 53.6 over the prior 199 months.

Below are key valuation metrics over time for EBS.

EBS Growth Metrics

Its 3 year cash and equivalents growth rate is now at 217.32%.
• The 2 year cash and equivalents growth rate now stands at 139.96%.
• Its 4 year revenue growth rate is now at 115.98%.

EBS's revenue has moved up $807,924,000 over the prior 49 months.

The table below shows EBS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	1,513.4	202.1	53.5
2022-06-30	1,602.4	292.8	96.5
2022-03-31	1,757.2	278.7	157.5
2021-12-31	1,792.7	321.1	230.9
2021-09-30	1,652.5	237.2	227
2021-06-30	1,708.7	325.7	299.2

EBS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• EBS has a Quality Grade of C, ranking ahead of 50.38% of graded US stocks.
• EBS's asset turnover comes in at 0.604 -- ranking 57th of 681 Pharmaceutical Products stocks.
• ARWR, IBIO, and MCRB are the stocks whose asset turnover ratios are most correlated with EBS.

The table below shows EBS's key quality metrics over time.